Literature DB >> 21651891

Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator.

Shanshan Yu1, Bo Gao, Zhijian Duan, Wei Xu, Sidong Xiong.   

Abstract

Increasing evidence suggests that TRIM family proteins may play important roles in the regulation of innate immune signaling pathways. Here we report TRIM22 is involved in the activation of NF-κB. It was found that overexpression of TRIM22 could dose-dependently activate NF-κB as demonstrated by reporter gene assay and electrophoretic mobility shift assay, but had no effect on the activity of other transcription factors, including NF-AT, AP-1, C/EBP and IRFs. Further study showed that both the N-terminal RING domain and C-terminal SPRY domain were crucial for TRIM22-mediated NF-κB activation. Moreover, our results revealed that TRIM22 overexpression could significantly induce the secretion of pro-inflammatory cytokines by human macrophage cell line U937 in an NF-κB-dependent manner. These data suggested that TRIM22 was a positive regulator of NF-κB-mediated transcription.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651891     DOI: 10.1016/j.bbrc.2011.05.124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

Review 1.  The cell biology of TRIM5α.

Authors:  Zana Lukic; Edward M Campbell
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

2.  Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.

Authors:  Inna G Ovsyannikova; Hannah M Salk; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2015-09-02       Impact factor: 2.846

3.  TRIM22 inhibits the TRAF6-stimulated NF-κB pathway by targeting TAB2 for degradation.

Authors:  Hui Qiu; Fang Huang; Han Xiao; Binlian Sun; Rongge Yang
Journal:  Virol Sin       Date:  2013-06-26       Impact factor: 4.327

4.  TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.

Authors:  Ravesh Singh; Vinod Patel; Marianne W Mureithi; Vivek Naranbhai; Duran Ramsuran; Sahil Tulsi; Keshni Hiramen; Lise Werner; Koleka Mlisana; Marcus Altfeld; Jeremy Luban; Victoria Kasprowicz; Keertan Dheda; Salim S Abdool Karim; Thumbi Ndung'u
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

5.  Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.

Authors:  Qi Li; Cheng Hiang Lee; Lauren A Peters; Lucas A Mastropaolo; Cornelia Thoeni; Abdul Elkadri; Tobias Schwerd; Jun Zhu; Bin Zhang; Yongzhong Zhao; Ke Hao; Antonio Dinarzo; Gabriel Hoffman; Brian A Kidd; Ryan Murchie; Ziad Al Adham; Conghui Guo; Daniel Kotlarz; Ernest Cutz; Thomas D Walters; Dror S Shouval; Mark Curran; Radu Dobrin; Carrie Brodmerkel; Scott B Snapper; Christoph Klein; John H Brumell; Mingjing Hu; Ralph Nanan; Brigitte Snanter-Nanan; Melanie Wong; Francoise Le Deist; Elie Haddad; Chaim M Roifman; Colette Deslandres; Anne M Griffiths; Kevin J Gaskin; Holm H Uhlig; Eric E Schadt; Aleixo M Muise
Journal:  Gastroenterology       Date:  2016-02-04       Impact factor: 22.682

6.  TRIM22: A Diverse and Dynamic Antiviral Protein.

Authors:  Clayton J Hattlmann; Jenna N Kelly; Stephen D Barr
Journal:  Mol Biol Int       Date:  2012-05-08

7.  Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.

Authors:  Chen Yang; Xinhao Zhao; Dakang Sun; Leilei Yang; Chang Chong; Yu Pan; Xiumei Chi; Yanhang Gao; Moli Wang; Xiaodong Shi; Haibo Sun; Juan Lv; Yuanda Gao; Jin Zhong; Junqi Niu; Bing Sun
Journal:  Cell Mol Immunol       Date:  2015-02-16       Impact factor: 11.530

8.  Knockdown of TRIM22 Relieves Oxygen-Glucose Deprivation/Reoxygenation-Induced Apoptosis and Inflammation Through Inhibition of NF-κB/NLRP3 Axis.

Authors:  Chongyang Kang; Zhaofeng Lu; Gangyi Zhu; Yuehua Chen; Yafang Wu
Journal:  Cell Mol Neurobiol       Date:  2020-04-25       Impact factor: 5.046

9.  Nucleo-cytoplasmic trafficking of TRIM8, a novel oncogene, is involved in positive regulation of TNF induced NF-κB pathway.

Authors:  Dhanendra Tomar; Lakshmi Sripada; Paresh Prajapati; Rochika Singh; Arun Kumar Singh; Rajesh Singh
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

10.  Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.

Authors:  Zhong-Ping Tang; Qian-Ze Dong; Quan-Zhe Cui; Paulie Papavassiliou; En-Di Wang; En-Hua Wang
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.